Bio-Techne Unveils Advanced Synthetic Hydrogel for Research
Bio-Techne Corporation (NASDAQ: TECH), a significant player in the life sciences sector, has announced an exciting expansion in its offerings with the introduction of the Cultrex Synthetic Hydrogel. This fully defined synthetic extracellular matrix (ECM) is poised to revolutionize 3D stem cell and organoid research.
Groundbreaking Features of Cultrex Synthetic Hydrogel
This cutting-edge ECM is engineered to enhance reproducibility and minimize lot-to-lot variability, which has been a challenge in traditional matrices. Researchers can now depend on this synthetic alternative to maintain consistent performance across various workflows.
Improving Reproducibility and Scalability
Cultrex Synthetic Hydrogel supports the standardization required for scalable 3D stem cell and organoid workflows. Its unique properties pave the way for more reliable and effective experimental conditions, which is vital as research teams navigate the complexities of their studies.
Aiming for Regulatory Alignment
In alignment with evolving regulatory standards, Cultrex Synthetic Hydrogel represents an important advancement in addressing the calls for innovative approaches in preclinical research. This product not only aligns with the FDA's objectives but also promotes the integration of new approach methodologies (NAMs) within the pharmaceutical sector.
Wider Applications for the Cultrex Hydrogel
This hydrogel is versatile and can be utilized in various applications, such as drug screening, toxicology assessments, and personalized medicine initiatives. By reducing reliance on animal-derived components, it supports ethical research practices while fostering scientific innovation.
Company Insights and Future Directions
Will Geist, President of the Protein Sciences Segment at Bio-Techne, highlights that this product addresses the evolving needs of researchers as they progress from basic studies to more complex translational workflows. The Cultrex Synthetic Hydrogel not only expands the Cultrex ECM portfolio but also reinforces Bio-Techne's commitment to providing exceptional solutions for the scientific community.
Bio-Techne’s robust portfolio includes not just Cultrex Synthetic Hydrogel but also Basement Membrane Extracts (BME), recombinant cytokines, AI-modified proteins, growth factors, small molecules, and various media and supplements tailored to the needs of modern scientific research.
Conclusion: A Step Forward in Research Innovation
The launch of Cultrex Synthetic Hydrogel signifies a remarkable step towards enhancing the tools available for stem cell and organoid research. By ensuring consistency and traceability, this hydrogel supports researchers as they strive to meet regulatory demands and push the boundaries of scientific exploration.
Frequently Asked Questions
What is Cultrex Synthetic Hydrogel?
Cultrex Synthetic Hydrogel is a fully defined synthetic extracellular matrix designed to improve reproducibility in 3D stem cell and organoid research.
How does it enhance research reproducibility?
It reduces lot-to-lot variability, allowing researchers to standardize conditions across different studies and labs.
What applications can the hydrogel be used for?
The hydrogel can be utilized for drug screening, toxicology studies, and personalized medicine, facilitating more ethical research practices.
Why is regulatory alignment important?
Regulatory alignment ensures that the tools used in research meet current industry standards, promoting safer and more reliable outcomes.
How does Bio-Techne support researchers?
Bio-Techne offers a wide array of innovative tools and reagents, helping scientists conduct effective and meaningful research across various scientific fields.
